This suggest that under pathological conditions, such as neuroinflammation when reactive oxygen species are produced, IL-13 and IL-4 can participate to tissue damage and thus to Parkinson’s disease or other neurodegenerative disorders. This evidence concerns the gene IL13 and Parkinson disease.